NFE2L2 and neoplasm: In Nrf2- activating MU group, there were fewer immune cells with dominant anti-tumor activity, such as Tregs, Th2 cells, Th1 cells, NK cells, Monocytes, T cells, CD8 + T cells, CD4 + T cells, and B cells (all p < 0.05, Fig. 8D).